Lenalidomide (Viatris) TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: lenalidomide
Brand name
(ARTG)
: LENALIDOMIDE VIATRIS lenalidomide 25 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide Viatris is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide Viatris is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,Mantle Cell Lymphoma (MCL),Lenalidomide Viatris is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- No.0, white opaque cap & white opaque body, hard-shell gelatin capsule axially printed with MYLAN over LL 25 in black ink on both cap and body.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE VIATRIS lenalidomide 25 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide Viatris is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide Viatris is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,Mantle Cell Lymphoma (MCL),Lenalidomide Viatris is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- No.0, white opaque cap & white opaque body, hard-shell gelatin capsule axially printed with MYLAN over LL 25 in black ink on both cap and body.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE VIATRIS lenalidomide 10 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide Viatris is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide Viatris is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,Mantle Cell Lymphoma (MCL),Lenalidomide Viatris is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- No.0, green opaque cap & light grey opaque body, hard-shell gelatin capsule axially printed with MYLAN over LL 10 in black ink on both cap and body.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE VIATRIS lenalidomide 10 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide Viatris is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide Viatris is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,Mantle Cell Lymphoma (MCL),Lenalidomide Viatris is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- No.0, green opaque cap & light grey opaque body, hard-shell gelatin capsule axially printed with MYLAN over LL 10 in black ink on both cap and body.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE VIATRIS lenalidomide 10 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide Viatris is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide Viatris is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,Mantle Cell Lymphoma (MCL),Lenalidomide Viatris is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- No.0, green opaque cap & light grey opaque body, hard-shell gelatin capsule axially printed with MYLAN over LL 10 in black ink on both cap and body.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE VIATRIS lenalidomide 15 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide Viatris is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide Viatris is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,Mantle Cell Lymphoma (MCL),Lenalidomide Viatris is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- No.0, white opaque cap & white opaque body, hard-shell gelatin capsule axially printed with MYLAN over LL 15 in red ink on both cap and body.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE VIATRIS lenalidomide 15 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide Viatris is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide Viatris is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,Mantle Cell Lymphoma (MCL),Lenalidomide Viatris is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- No.0, white opaque cap & white opaque body, hard-shell gelatin capsule axially printed with MYLAN over LL 15 in red ink on both cap and body.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE VIATRIS lenalidomide 15 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide Viatris is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide Viatris is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,Mantle Cell Lymphoma (MCL),Lenalidomide Viatris is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- No.0, white opaque cap & white opaque body, hard-shell gelatin capsule axially printed with MYLAN over LL 15 in red ink on both cap and body.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE VIATRIS lenalidomide 5 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide Viatris is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide Viatris is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,Mantle Cell Lymphoma (MCL),Lenalidomide Viatris is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- No.2, white opaque cap & white opaque body, hard-shell gelatin capsule axially printed with MYLAN over LL 5 in black ink on both cap and body.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE VIATRIS lenalidomide 5 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide Viatris is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide Viatris is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,Mantle Cell Lymphoma (MCL),Lenalidomide Viatris is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- No.2, white opaque cap & white opaque body, hard-shell gelatin capsule axially printed with MYLAN over LL 5 in black ink on both cap and body.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Is this medicine subsidised ?
(PBS)
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on December, 1 2024. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE VIATRIS lenalidomide 5 mg capsule blister packDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide Viatris is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide Viatris is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,Mantle Cell Lymphoma (MCL),Lenalidomide Viatris is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- No.2, white opaque cap & white opaque body, hard-shell gelatin capsule axially printed with MYLAN over LL 5 in black ink on both cap and body.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 14 pack
- 21 pack
- 28 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE VIATRIS lenalidomide 2.5 mg capsule blister packWhat this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide Viatris is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide Viatris is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,Mantle Cell Lymphoma (MCL),Lenalidomide Viatris is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- No.4, green opaque cap & white opaque body, hard-shell gelatin capsule axially printed with MYLAN over LL 2.5 in black ink on both cap and body.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 21 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE VIATRIS lenalidomide 7.5 mg capsule blister packWhat this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide Viatris is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide Viatris is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,Mantle Cell Lymphoma (MCL),Lenalidomide Viatris is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- No.2, light gray opaque cap & white opaque body, hard-shell gelatin capsule axially printed with MYLAN over LL 7.5 in black ink on both cap and body.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 21 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
Brand name
(ARTG)
: LENALIDOMIDE VIATRIS lenalidomide 20 mg capsule blister packWhat this medicine is used for
(ARTG)
Multiple Myeloma (MM),Lenalidomide Viatris is indicated for the treatment of multiple myeloma.,Myelodysplastic Syndromes (MDS),Lenalidomide Viatris is indicated for treatment of patients with transfusion-dependent anaemia due to low- or intermediate-1 risk myelodysplastic syndromes associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities.,Mantle Cell Lymphoma (MCL),Lenalidomide Viatris is indicated for the treatment of patients with relapsed and/or refractory mantle cell lymphoma.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Capsule
- Oral
- No.0, green opaque cap and white opaque body, hard-shell gelatin capsule axially printed with MYLAN over LL 20 in red ink on both cap and body.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Store in Original Container
- Shelf lifetime is 36 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- 21 pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lenalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems